Skip to website navigation Skip to article navigation Skip to content

A page refresh occures when a subject is selected.

Skip article navigation.

2. Consolidated financial statements

2.1 Consolidated income statement

2.1 Consolidated income statement

For the year ended December 31

   

€ million

Note

2020

2019

Continuing operations

   

Net Sales

6

5 052

4 680

Royalty income and fees

 

96

78

Other revenue

10

199

155

Revenue

 

5 347

4 913

Cost of sales

 

-1 363

-1 268

Gross profit

 

3 984

3 645

Marketing and selling expenses

 

-1 221

-1 108

Research and development expenses

 

-1 569

-1 272

General and administrative expenses

 

- 196

- 195

Other operating income/expenses (-)

13

95

48

Operating profit before impairment, restructuring

 

1 093

1 118

and other income and expenses

Impairment of non-financial assets

14

0

- 2

Restructuring expenses

15

- 20

- 47

Other income/expenses (-)

16

- 102

- 1

Operating profit

 

971

1 068

Financial income

17

14

18

Financial expenses

17

- 107

- 125

Share of profit/loss (-) of associates

 

2

- 1

Profit before income taxes

 

880

960

Income tax expense

18

- 119

- 146

Profit from continuing operations

 

761

814

Discontinued operations

   

Profit/loss (-) from discontinued operations

9

0

2

Profit

 

761

817

Attributable to:

   

Equity holders of UCB SA

 

732

792

Non-controlling interests

 

29

25

Basic earnings per share (€)

   

from continuing operations

41

3.87

4.22

from discontinued operations

41

0.00

0.01

Total basic earnings per share

 

3.87

4.23

Diluted earnings per share (€)

   

from continuing operations

41

3.77

4.09

from discontinued operations

41

0.00

0.01

Total diluted earnings per share

 

3.77

4.10